| 证券代码：603058 | 证券简称：永吉股份 | 公告编号：2023-060 | | --- | --- | --- | | 转债代码：113646 | 转债简称：永吉转债 | | 贵州永吉印务股份有限公司 关于召开 2022 年度业绩说明会的公告 本次投资者说明会以视频结合网络互动召开，公司将针对 2022 年度经营成 果及财务指标的具体情况与投资者进行互动交流和沟通，在信息披露允许的范围 内就投资者普遍关注的问题进行回答。 二、说明会召开的时间、地点 （网址：http://roadshow.sseinfo.com/） 会议召开时间：2023 年 06 月 13 日(星期二) 上午 10:00-11:30 会议召开地点：上海证券交易所上证路演中心 （一）会议召开时间：2023 年 06 月 13 日 上午 10:00-11:30 会议召开方式：上证路演中心视频直播和网络互动 投资者可于 2023 年 06 月 06 日(星期二) 至 06 月 12 日(星期一)16:00 前登 录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 dsh@yongjigf.com 进行提问。公司将在说明会上对投 ...

| 证券代码：603058 | 证券简称：永吉股份 公告编号：2023-053 | | --- | --- | | 转债代码：113646 | 转债简称：永吉转债 | 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 贵州永吉印务股份有限公司 关于参加贵州辖区上市公司投资者线上集体接 待日活动暨线上业绩说明会的公告 贵州永吉印务股份有限公司（以下简称"公司"）于 2023 年 3 月 31 日在上 海证券交易所网站（www.sse.com.cn）披露了《2022 年年度报告》。为加强与 投资者的互动交流和沟通，使投资者更加全面、深入地了解公司 2022 年度经营 成果、财务状况，公司将参加由贵州证监局、贵州证券业协会与深圳市全景网络 有限公司联合举办的贵州辖区上市公司投资者集体接待日暨 2022 年度业绩说明 会活动。本次年度业绩说明会将采用网络远程的方式举行，投资者可登陆"全景 路演"（http://rs.p5w.net）参与本次年度业绩说明会。 重要内容提示： ● 会议召开形式：网络文字互动 ● 会议召开形式：提问通道自本公 ...

Financial Performance - The company's operating revenue for Q1 2023 reached ¥173,862,414.52, representing a year-on-year increase of 47.25%[3] - Net profit attributable to shareholders was ¥30,906,162.14, with a significant increase in net profit excluding non-recurring gains and losses to ¥30,982,916.52, up 1,038.31%[3] - Operating profit for Q1 2023 was ¥35,911,110.01, recovering from a loss of ¥27,960,757.81 in Q1 2022[20] - Net profit for Q1 2023 was ¥30,202,186.00, compared to a net loss of ¥24,529,016.58 in Q1 2022, marking a turnaround[20] - The total comprehensive income for Q1 2023 was ¥26,494,899.22, compared to a loss of ¥18,981,156.40 in Q1 2022, indicating improved overall performance[20] - The company reported a basic earnings per share of ¥0.072 for Q1 2023, recovering from a loss of ¥0.058 per share in Q1 2022[20] Cash Flow - The net cash flow from operating activities was ¥7,193,699.34, indicating a positive cash flow situation[3] - Cash flow from operating activities generated a net amount of ¥7,193,699.34 in Q1 2023, a recovery from a negative cash flow of ¥51,726,427.74 in Q1 2022[23] - The net cash flow from investment activities was $114,792,963.62, a significant improvement compared to a negative cash flow of -$42,075,675.35 in the previous period[24] - Cash and cash equivalents at the end of the period totaled $376,176,015.93, up from $259,071,664.47 in the previous period[24] - The net cash flow from financing activities was -$1,739,551.30, compared to a positive cash flow of $333,008.95 in the previous period[24] - The company’s cash flow from financing activities included $14,797,404.00 for debt repayment, reflecting a strategic focus on managing liabilities[24] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,760,183,775.95, showing a slight increase of 0.01% compared to the end of the previous year[4] - The total current assets decreased to CNY 797,223,833.25 from CNY 892,522,583.51, indicating a decline of about 10.6%[16] - The company's long-term equity investments rose to CNY 60,319,464.55 from CNY 50,283,474.42, reflecting an increase of approximately 19.9%[16] - The total liabilities decreased to CNY 551,688,228.03 from CNY 578,034,230.44, showing a reduction of about 4.6%[17] - The company's accounts receivable decreased to CNY 123,698,335.82 from CNY 168,641,151.74, representing a decline of approximately 26.6%[15] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 14,238, with the largest shareholder holding 41.18% of the shares[7] - The company plans to implement a cash dividend of CNY 2.5 per 10 shares for the 2022 fiscal year, subject to shareholder approval[13] Research and Development - Research and development expenses surged by 77.14%, reflecting the company's increased investment in new products and technologies[6] - Research and development expenses increased to ¥9,202,666.51 in Q1 2023, up from ¥5,195,045.47 in Q1 2022, reflecting a focus on innovation[19] Future Plans - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[6] - The company is in the process of a non-public offering of A-shares, with relevant proposals approved by the board in early 2023[12] - The company completed the registration of the 2022 restricted stock incentive plan on February 28, 2023, following board and shareholder approvals[10] Other Information - The report was officially announced by the board of directors on April 28, 2023[26] - The company did not apply new accounting standards for the first quarter of 2023[25]

Dividend Distribution - The company plans to distribute a cash dividend of 2.5 yuan (pre-tax) for every 10 shares, totaling approximately 103,674,964.50 yuan for the year 2022[6]. - The cash dividend distribution date is set for September 30, 2022, with the record date being September 29, 2022[6]. - The company does not plan to issue new shares or convert capital reserves into share capital in the current profit distribution[6]. - The company’s cash dividends are contingent upon achieving positive distributable profits and receiving an unqualified audit opinion on financial reports[138]. - The company implements an active dividend distribution policy, prioritizing cash dividends, which should not be less than 20% of the distributable profit for the year[138]. Financial Performance - The company achieved a total revenue of RMB 653.34 million in 2022, representing a year-on-year increase of 49.86%[23]. - Net profit attributable to shareholders decreased by 72.54% to RMB 37.78 million, while the net profit after deducting non-recurring gains and losses increased by 253.55% to RMB 82.73 million[23]. - Operating cash flow increased by 173.09% to RMB 100.23 million, driven by significant growth in sales revenue[25]. - The company's weighted average return on equity decreased by 8.37 percentage points to 3.41%[25]. - Basic earnings per share fell to RMB 0.0911, a decrease of 72.39% compared to the previous year[24]. Revenue Breakdown - Sales revenue from cigarette labels increased by 54.35%, and sales from medical cannabis in Australia surged by 2084.95%[25]. - The revenue from the cigarette label business was 460.47 million yuan, up 54.35% year-on-year, while the wine label business revenue reached 109.08 million yuan, growing by 15.81%[32]. - In the medical cannabis sector, the company’s subsidiary TB achieved sales revenue of 8.2936 million AUD (approximately 38.70451 million yuan), a year-on-year increase of 2084.95%[51]. Assets and Liabilities - The total assets of the company at the end of 2022 were RMB 1.76 billion, an increase of 4.82% from the previous year[23]. - The company reported a net asset attributable to shareholders of RMB 1.05 billion, down 4.39% from the previous year[23]. - The company’s equity attributable to the parent company was 1.05 billion yuan, a decrease of 4.39% from the beginning of the reporting period[61]. Research and Development - The company invested 35,247,549.52 yuan in R&D, an increase of 13.56% year-on-year, and developed a total of 240 new product samples, with 70 products entering production[35]. - The company developed and sampled 50 new cigarette label products in 2022, with 7 products entering production[60]. - For wine label products, the company developed and sampled 174 products, with 50 products entering production[60]. Market Expansion - The company plans to continue expanding its product offerings and market presence, particularly in the medical cannabis sector[25]. - The company is actively pursuing opportunities in the industrial hemp market, which has shown significant growth potential, particularly in Australia[42]. - The company is exploring the development of industrial hemp applications, with a focus on plant-based protein and hemp core materials, aiming to expand into the consumer goods and health industries[37]. Corporate Governance - The company has established a comprehensive governance structure to protect the rights of all shareholders, especially minority shareholders[113]. - The board of directors consists of three members, all of whom are independent directors, ensuring compliance with legal requirements[114]. - The company has not faced any penalties from securities regulatory agencies in the past three years[125]. Environmental Responsibility - The company invested 930,000 RMB in environmental protection during the reporting period[150]. - The company effectively managed wastewater, with all production wastewater being recycled and treated, ensuring compliance with national standards[152]. - The company implemented measures to control emissions of VOCs and other pollutants, with all monitored emissions below regulatory limits[153]. Shareholder Structure - The largest shareholder, Guizhou Yongji Holdings Co., Ltd., holds 172,566,200 shares, representing 41.18% of the total shares, with 84,557,400 shares pledged[199]. - The total number of ordinary shareholders increased from 14,117 to 14,570 during the reporting period[197]. - The top ten shareholders include a mix of corporate and individual investors, with the largest individual shareholder, Deng Weijia, holding 22,000,000 shares, or 5.25%[199]. Risk Management - The company is facing risks from raw material price fluctuations, with direct materials accounting for approximately 70% of its operating costs[108]. - The company is closely monitoring exchange rate fluctuations, particularly between the RMB and AUD, to manage foreign exchange risk[111]. - The company is facing intensified competition in the tobacco industry, leading to potential price reductions and profit margin compression[110].

2022 年第三季度报告 证券代码：603058 证券简称：永吉股份 一、 主要财务数据 贵州永吉印务股份有限公司 2022 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期 比上年同 | | 年初至报告期 末比上年同期 | | --- | --- | --- | --- | --- | | | | | 年初至报告期末 | | | | | 期增减变 | | 增减变动幅度 | | | | 动幅度(%) | | (%) | | 营业收入 | 128,581,610.22 | 29.74 | 380,023,950.04 | 37.29 | | 归属于上市公司股东的 | -25,918,008.72 | -156.14 | -13,417,034.87 | -109.98 | | 净利润 | | | | | | 归属于上市公司股东的 | | | | | | 扣除非经常性损益的净 | 8,619,542.67 | ...

Financial Performance - The company achieved operating revenue of RMB 251.44 million, an increase of 41.50% compared to the same period last year[21]. - Net profit attributable to shareholders decreased by 85.83% to RMB 12.50 million, while the net profit excluding non-recurring gains and losses increased by 24.15% to RMB 23.27 million[21]. - The weighted average return on net assets decreased by 6.22 percentage points to 1.13%[20]. - Total assets increased by 6.50% to RMB 1.79 billion compared to the end of the previous year[21]. - The net cash flow from operating activities decreased by 41.29% to RMB 53.31 million[20]. - The company reported a loss of RMB 14.40 million from investments in private equity funds, a decrease of 118.61% compared to the previous year's similar business income[21][23]. - The company’s net assets attributable to shareholders increased by 2.39% to RMB 1.13 billion compared to the end of the previous year[20]. - The company reported a net profit of 12.50 million yuan, a decline of 85.83% year-on-year, primarily due to losses in securities investments[46]. Revenue Breakdown - The sales revenue from tobacco label products increased by 49.36% to RMB 170.42 million, while the sales revenue from wine label products grew by 18.01% to RMB 49.53 million[21]. - The overseas subsidiary TB achieved sales revenue of RMB 12.15 million, a significant increase of 135.42% year-on-year[21]. - Revenue from the cigarette label business was 170.42 million yuan, up 49.36% year-on-year, while the wine label business generated 49.53 million yuan, an increase of 18.01%[46]. - The company achieved a sales revenue of 49.53 million RMB for wine labels in the first half of 2022, representing an 18.01% increase compared to the same period last year[32]. Product Development and Innovation - The company designed and developed 75 wine label products during the reporting period, with 7 products entering mass production[32]. - The company plans to launch 2-5 new products in the medical cannabis sector in the next six months, including high THC flower products[35]. - The company invested 12.13 million yuan in R&D during the reporting period, reflecting a year-on-year increase of 21.08%[47]. - The company developed 17 new cigarette label products, with 7 entering mass production, and 75 new wine label products, with 7 also in production[43]. Environmental Compliance - The company has implemented strict pollution control measures, ensuring that wastewater discharge complies with national standards, with no exceedance reported[80]. - The company has established effective waste gas treatment systems, with emissions from ink and oil smoke meeting regulatory requirements[82]. - The company has received the Pollution Discharge Permit from the Guizhou Provincial Environmental Protection Bureau, confirming compliance with environmental regulations[85]. - The company has set up an emergency response plan for environmental pollution incidents, which has been filed with local environmental authorities[86]. Financial Structure and Capital Management - The company issued 1,458,680 convertible bonds in April 2022, raising a total of 145.868 million yuan[100]. - The company’s controlling shareholder has committed to measures to mitigate the dilution of immediate returns due to the issuance of convertible bonds[101]. - The company’s board and senior management have pledged to uphold their duties and ensure compliance with regulations regarding the execution of return compensation measures[103]. - As of June 30, 2022, the company had a debt-to-asset ratio of 29.58%, indicating a stable financial structure[125]. Shareholder Information - The total number of ordinary shareholders as of the end of the reporting period was 18,534[111]. - The largest shareholder, Guizhou Yongji Holding Co., Ltd., held 172,566,200 shares, accounting for 41.18% of the total shares[114]. - The company completed a share buyback, with the repurchased shares totaling 4,379,000, representing 1.0449% of the total share capital[114]. Risk Management - The company emphasizes the importance of risk awareness regarding future plans and development strategies[5]. - The report includes a section on major risks that investors should review[6]. - The company is closely monitoring exchange rate fluctuations, particularly between the CNY and AUD, to manage foreign exchange risks effectively[71]. Corporate Governance - The company guarantees the authenticity, accuracy, and completeness of the semi-annual report, with all directors present at the board meeting[7]. - There are no non-operating fund occupations by controlling shareholders or related parties[6]. - The company has no violations in decision-making procedures for external guarantees[6]. Accounting and Financial Reporting - The company prepares financial statements based on actual transactions and events in accordance with the accounting standards issued by the Ministry of Finance[166]. - The financial statements reflect the company's financial position, operating results, changes in shareholders' equity, and cash flows accurately and completely[169]. - The company's accounting period runs from January 1 to December 31 each year[170].

Dividend Policy - The company plans to distribute a cash dividend of 2.5 yuan per 10 shares, totaling 103.7 million yuan, based on the total share capital after deducting repurchased shares[5] - The company will not distribute cash dividends or increase capital reserves through stock conversion for the current period, aligning with its operational needs and development strategy[5] - The company has a cash dividend policy that mandates a minimum of 20% of the distributable profit to be distributed in cash if conditions are met[143] - In mature stages without major capital expenditure plans, the cash dividend proportion should be at least 80% of the profit distribution[144] - The company’s cash dividend conditions include a positive distributable profit and an unqualified audit report for the financial statements[144] - The company actively communicates with minority shareholders to gather their opinions on profit distribution plans[145] Financial Performance - In 2021, the company's operating revenue was CNY 435.98 million, a decrease of 0.65% compared to 2020[22] - The net profit attributable to shareholders was CNY 137.58 million, down 12.95% from the previous year[22] - The net profit after deducting non-recurring gains and losses was CNY 23.40 million, a significant decline of 71.26% year-on-year[24] - The net cash flow from operating activities was CNY 36.70 million, a decrease of 76.05% compared to 2020[22] - The company's total assets increased by 10.78% year-on-year, reaching CNY 1.68 billion by the end of 2021[22] - The basic earnings per share were CNY 0.33, reflecting a decrease of 13.16% from the previous year[23] - The gross profit margin for the year was 28.11%, with operating costs rising by 12.23% due to fluctuations in raw material prices[62] - The company achieved total revenue of CNY 435.98 million in 2021, a decrease of 0.65% compared to the previous year[61] Business Segments - The company’s wine label business grew approximately 117% year-on-year, while the cigarette label sales revenue decreased by about 15% due to price adjustments[24] - Revenue from the cigarette label business was 298.32 million yuan, a decline of 14.88% year-on-year, while revenue from the wine label business increased by 117.48% to 94.19 million yuan[35] - The company developed and sampled 148 new wine label products in 2021, with over 50% of them successfully entering production[52] - The company invested 40 million AUD to build a modern cannabis cultivation and processing center, now the largest medical cannabis base in the Southern Hemisphere[54] - The revenue from the medical cannabis segment was approximately $1.77 million, with a gross margin of 43.87%, showing a significant decline of 62.47% compared to the previous year[66] Research and Development - The company invested 31,039,191.66 yuan in R&D, representing a year-on-year increase of 46.81%[37] - The company designed and sampled 30 design schemes for major clients, with several products already launched in the market[36] - The company has submitted patents for new designs and optimizations in its product development process[56] - Research and development expenses increased by 46.81% to CNY 31.04 million, reflecting a commitment to innovation[62] Market Expansion and Strategy - The company plans to expand into the industrial hemp sector, focusing on plant-based protein and hemp core materials[40] - The company aims to enhance its competitiveness by optimizing product structure and expanding its customer base[39] - The company is actively pursuing market opportunities in the high-end liquor packaging sector, responding to government policies and consumer trends[103] - The company is focused on expanding its market presence in regions like Hubei, Zhejiang, and Yunnan for tobacco label printing, aiming for increased order share[102] - The company plans to leverage its resources and capital advantages to diversify its product offerings and reduce client concentration risks[100] Governance and Compliance - The board of directors and management guarantee the authenticity, accuracy, and completeness of the annual report[10] - The company has established a governance structure to enhance decision-making and compliance with legal regulations[153] - The company has established specialized committees under the board, including audit, nomination, compensation and assessment, and strategy committees[116] - The company has not encountered significant differences in governance compared to regulations set by the China Securities Regulatory Commission[117] - The company has a mechanism to deduct cash dividends from shareholders who improperly occupy company funds[147] Environmental and Safety Practices - The company has implemented measures to treat wastewater and emissions, ensuring compliance with environmental standards[157] - The company has established a comprehensive emergency response plan for environmental pollution incidents, which has been filed with local environmental authorities[162] - The company conducts quarterly monitoring of wastewater discharge, focusing on parameters such as COD, BOD5, and total phosphorus[169] - The company has a zero discharge policy for wastewater, with the main source of wastewater being domestic sewage[169] - The company has implemented safety measures for hazardous waste management, including strict adherence to national regulations and designated management personnel[162] Shareholding Structure - The total number of ordinary shareholders as of the end of the reporting period is 22,612, an increase from 21,455 at the end of the previous month[190] - The largest shareholder, Guizhou Yongji Holdings Co., Ltd., holds 172,566,200 shares, representing 41.18% of the total shares, with 111,810,000 shares pledged[192] - The total number of shares held by the top ten shareholders is 290,000,000, which constitutes a significant portion of the company's equity[192] - The company has a repurchase account holding 4,258,000 shares, representing 1.02% of the total share capital[193] - The cumulative pledged shares of the controlling shareholder or the largest shareholder and their concerted actors do not exceed 80% of their holdings[199]

2022 年第一季度报告 证券代码：603058 证券简称：永吉股份 贵州永吉印务股份有限公司 2022 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务报表 信息的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 项目 本报告期 本报告期比上年同期 增减变动幅度(%) 营业收入 118,072,243.10 16.47 归属于上市公司股东的净利润 -24,201,298.79 -623.20 归属于上市公司股东的扣除非经常性损益的净利润 2,721,830.07 -85.13 经营活动产生的现金流量净额 -51,726,427.74 -2,228.60 基本每股收益（元/股） -0. ...

[Main Financial Data](index=1&type=section&id=Item%20I.%20Main%20Financial%20Data) This section details the company's key financial data, including significant changes in accounting metrics, non-recurring items, and their underlying causes [Key Accounting Data and Financial Indicators](index=1&type=section&id=(I)%20Key%20Accounting%20Data%20and%20Financial%20Indicators) The company experienced mixed financial performance in Q3 2021, with strong net profit growth driven by non-core activities despite a decline in cumulative revenue and operating cash flow Key Accounting Data and Financial Indicators | Item | Current Period (Q3 2021) | YTD Reporting Period (YTD Q3 2021) | YTD YoY Change (%) | | :--- | :--- | :--- | :--- | | Operating Revenue (Ten Thousand Yuan) | 9,911.07 | 27,680.27 | -2.87% | | Net Profit Attributable to Shareholders (Ten Thousand Yuan) | 4,616.63 | 13,440.41 | 23.28% | | Net Profit Attributable to Shareholders (Excluding Non-Recurring Items) (Ten Thousand Yuan) | -121.90 | 1,752.42 | -70.83% | | Net Cash Flow from Operating Activities (Ten Thousand Yuan) | -1,422.65 | 7,657.77 | -26.58% | | Total Assets (Period-end) (Hundred Million Yuan) | 16.41 | 16.41 | 8.25% (vs. prior year-end) | | Shareholders' Equity Attributable to Parent (Period-end) (Hundred Million Yuan) | 11.04 | 11.04 | -5.27% (vs. prior year-end) | [Non-Recurring Gains and Losses Items and Amounts](index=2&type=section&id=(II)%20Non-Recurring%20Gains%20and%20Losses%20Items%20and%20Amounts) Non-recurring gains and losses, primarily from securities investments, significantly contributed to the company's net profit, totaling 117 million yuan YTD Non-Recurring Gains and Losses Items and Amounts | Item | YTD Reporting Period Amount (Yuan) | Description | | :--- | :--- | :--- | | Securities Investment Related Gains/Losses | 134,083,684.65 | Investment income and fair value changes from private equity investment funds | | Government Grants | 2,104,441.92 | Received government subsidies | | Disposal Gains/Losses on Non-current Assets | 900,950.65 | Disposal of machinery and equipment | | **Total** | **116,879,897.62** | | [Analysis of Changes in Key Financial Data and Indicators](index=3&type=section&id=(III)%20Analysis%20of%20Changes%20in%20Key%20Accounting%20Data%20and%20Financial%20Indicators) Significant changes in financial indicators were observed, driven by increased assets from new products and projects, surging liabilities from financing and dividends, and substantial growth in investment income and R&D expenses - Balance Sheet Item Changes: - **Inventory** increased by **44.52%** due to an increase in wine box and cannabis products[8](index=8&type=chunk) - **Construction in Progress** increased by **166.05%** due to an increase in subsidiary construction projects[8](index=8&type=chunk) - **Other Non-current Assets** increased by **508.20%** due to an increase in overseas subsidiary's prepaid greenhouse construction and equipment advances[8](index=8&type=chunk) - **Other Payables** increased by **1,758.61%** due to an increase in interim dividend payables[8](index=8&type=chunk) - Income Statement Item Changes: - **R&D Expenses** increased by **94.01%** due to increased R&D investment[8](index=8&type=chunk) - **Investment Income** increased by **312.17%** due to an increase in realized gains from securities investments[8](index=8&type=chunk) - **Fair Value Change Gains** increased by **88.25%** due to an increase in unrealized gains from securities investments[8](index=8&type=chunk) - Cash Flow Statement Item Changes: - **Cash paid for goods and services** increased by **263.14%** due to an increase in cash payments for materials[8](index=8&type=chunk) - **Cash received from investment income** increased by **363.53%** due to an increase in redemption of securities investments year-on-year[8](index=8&type=chunk) - **Cash paid for acquisition of fixed assets, intangible assets, and other long-term assets** increased by **680.85%** due to an increase in subsidiary construction project payments[8](index=8&type=chunk) [Shareholder Information](index=4&type=section&id=Item%20II.%20Shareholder%20Information) This section outlines the company's shareholder structure, including the total number of shareholders and the shareholding status of the top ten shareholders [Shareholding Status of Shareholders](index=4&type=section&id=(I)%20Total%20Common%20Shareholders%2C%20Number%20of%20Preferred%20Shareholders%20with%20Restored%20Voting%20Rights%20and%20Top%20Ten%20Shareholders%27%20Shareholding%20Status) As of the reporting period end, the company had 15,262 common shareholders, with the top ten holding a significant stake, including the controlling shareholder's pledged shares and 1.02% held in the repurchase account - Total common shareholders at the end of the reporting period were **15,262**[9](index=9&type=chunk) Top Ten Shareholders' Shareholding Status | Shareholder Name | Shareholding Percentage (%) | Share Status | | :--- | :--- | :--- | | Guizhou Yongji Holding Co., Ltd. | 41.18 | Pledged 111,810,000 shares | | Guizhou Yunshang Printing Co., Ltd. | 8.58 | Frozen 5,824,000 shares | | Guizhou Yumei Paper Co., Ltd. | 7.78 | Pledged 32,624,000 shares | | Deng Weijia | 5.25 | None | - Controlling shareholder Guizhou Yongji Holding Co., Ltd. forms a concerted action relationship with Deng Weijia and Deng Daixing[10](index=10&type=chunk) - As of the end of the reporting period, the company held **4,258,000** shares through its dedicated share repurchase account, representing **1.02%** of the total share capital[10](index=10&type=chunk) [Other Significant Matters](index=5&type=section&id=Item%20III.%20Other%20Reminders) This section highlights other important operational information for investors, including share repurchases, profit distribution, external investments, and convertible bond issuance [Important Information on Operating Performance](index=5&type=section&id=Other%20Important%20Information%20on%20the%20Company%27s%20Operating%20Performance%20Requiring%20Investor%20Attention) The company actively pursued strategic initiatives, including a share repurchase, interim dividend distribution, a significant investment into the semiconductor sector, and preparation for convertible bond issuance - **Share Repurchase**: Planned to repurchase shares worth **30 million to 50 million yuan**. As of September 30, **4,258,000** shares have been repurchased, representing **1.016%** of total share capital, with a total payment of **29,144,925.41 yuan**[11](index=11&type=chunk) - **Profit Distribution**: Implemented 2021 interim profit distribution, paying cash dividends totaling **103.7 million yuan** on October 13, 2021[12](index=12&type=chunk)[13](index=13&type=chunk) - **External Investment**: Invested **107 million yuan** to increase capital in Shanghai Aiyan Semiconductor Co., Ltd., holding a **51%** stake post-investment, marking the company's expansion into the semiconductor sector[14](index=14&type=chunk) - **Convertible Bond Issuance**: Public issuance of convertible corporate bonds has been approved by the China Securities Regulatory Commission (CSRC) and is currently in the pre-issuance preparation phase[15](index=15&type=chunk) [Quarterly Financial Statements](index=6&type=section&id=Item%20IV.%20Quarterly%20Financial%20Statements) This section presents the company's consolidated quarterly financial statements, including the balance sheet, income statement, and cash flow statement [Consolidated Balance Sheet](index=6&type=section&id=Consolidated%20Balance%20Sheet) As of September 30, 2021, total assets increased to 1.641 billion yuan driven by construction and inventory, while total liabilities surged to 439 million yuan due to new borrowings and dividends, and equity decreased to 1.104 billion yuan due to share repurchases Key Asset Items | Key Asset Items | September 30, 2021 (Yuan) | December 31, 2020 (Yuan) | Reason for Change | | :--- | :--- | :--- | :--- | | Inventory | 142,569,487.51 | 98,650,891.23 | Increase in wine box and cannabis products | | Construction in Progress | 81,244,153.78 | 30,536,924.30 | Increase in subsidiary construction projects | | Other Non-current Assets | 83,994,582.86 | 13,810,385.93 | Prepaid equipment and project advances | | **Total Assets** | **1,640,757,556.63** | **1,515,686,686.30** | | Key Liability and Equity Items | Key Liability and Equity Items | September 30, 2021 (Yuan) | December 31, 2020 (Yuan) | Reason for Change | | :--- | :--- | :--- | :--- | | Short-term Borrowings | 96,096,913.43 | 0 | Increase in bank financing | | Other Payables | 104,298,047.09 | 5,611,613.30 | Primarily 103.7 million yuan in dividends payable | | Treasury Stock | 29,144,923.09 | 4,457,027.63 | Increase from company share repurchases | | **Total Liabilities** | **438,773,587.13** | **244,794,515.06** | | [Consolidated Income Statement](index=9&type=section&id=Consolidated%20Income%20Statement) In Q1-Q3 2021, operating revenue slightly decreased, but net profit attributable to parent company shareholders grew significantly to 134 million yuan, primarily driven by non-operating gains and increased R&D and administrative expenses Consolidated Income Statement | Item | Q1-Q3 2021 (Yuan) | Q1-Q3 2020 (Yuan) | YoY Change | | :--- | :--- | :--- | :--- | | Operating Revenue | 276,802,718.39 | 284,977,925.76 | -2.87% | | Net Profit Attributable to Parent Company Shareholders | 134,404,115.57 | 109,019,378.69 | +23.28% | | Investment Income | 77,937,121.64 | 18,909,135.47 | +312.17% | | Fair Value Change Gains | 56,294,616.63 | 29,904,344.90 | +88.25% | | R&D Expenses | 20,739,234.98 | 10,689,600.30 | +94.01% | [Consolidated Cash Flow Statement](index=11&type=section&id=Consolidated%20Cash%20Flow%20Statement) In Q1-Q3 2021, operating cash flow decreased due to higher payments for goods, while investing cash outflow significantly narrowed, and financing cash flow saw an inflow from borrowings and minority investments, with the period-end cash balance at 399 million yuan Consolidated Cash Flow Statement | Item | Q1-Q3 2021 (Yuan) | Q1-Q3 2020 (Yuan) | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | 76,577,721.17 | 104,295,646.87 | | Net Cash Flow from Investing Activities | -22,358,766.35 | -273,514,222.57 | | Net Cash Flow from Financing Activities | 13,695,239.57 | 4,105,702.99 | | Net Increase in Cash and Cash Equivalents | 66,636,076.61 | -153,404,657.54 | - Cash outflow from investing activities significantly decreased, primarily due to "cash paid for other investing activities" falling from **351 million yuan** in the prior year to **137 million yuan**, while "cash received from investment income" increased from **16.85 million yuan** to **78.11 million yuan**[29](index=29&type=chunk)[30](index=30&type=chunk)

Financial Performance - The company's operating revenue for the first half of 2021 was ¥177,692,033.99, a decrease of 10.61% compared to ¥198,776,030.17 in the same period last year[19]. - The net profit attributable to shareholders for the first half of 2021 was ¥88,237,815.58, an increase of 12.10% from ¥78,716,249.84 in the previous year[19]. - The net profit after deducting non-recurring gains and losses was ¥18,743,237.38, down 57.58% from ¥44,186,955.90 in the same period last year[19]. - The net cash flow from operating activities was ¥90,804,213.85, an increase of 19.41% compared to ¥76,045,590.38 in the previous year[19]. - Basic earnings per share for the first half of 2021 were ¥0.21, an increase of 10.53% from ¥0.19 in the same period last year[20]. - The company's operating costs were approximately ¥124.10 million, a slight decrease of 0.28% from ¥124.45 million year-on-year[47]. - The company reported a net profit for the first half of 2021 of ¥86,419,483.24, representing a 9.19% increase from ¥78,968,142.94 in the first half of 2020[117]. - The total operating income for the first half of 2021 reached ¥99,320,344.49, up from ¥82,232,651.88 in the previous year, indicating a growth of 20.7%[124]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,550,404,223.41, an increase of 2.29% from ¥1,515,686,686.30 at the end of the previous year[19]. - The net assets attributable to shareholders at the end of the reporting period were ¥1,203,447,985.42, up 3.26% from ¥1,165,464,455.98 at the end of the previous year[19]. - Total liabilities were CNY 243,395,270.44, slightly down from CNY 244,794,515.06 at the end of 2020[109]. - The company's total assets reached CNY 1,307,870,570.26, an increase from CNY 1,271,149,074.86 at the end of the previous period[115]. - Current assets totaled CNY 810,825,999.64, down from CNY 878,540,446.48 at the end of 2020, reflecting a decrease of approximately 7.7%[107]. Investment and Cash Flow - The company reported investment income of CNY 27,780,590.33, up from CNY 18,400,322.96 in the previous year[116]. - The net cash flow from investment activities was -265,052,382.42 RMB, indicating a significant outflow compared to the previous period[129]. - The total cash inflow from financing activities was 69,355,387.53 RMB, while the cash outflow was 61,992,761.97 RMB, resulting in a net cash flow of -61,992,761.97 RMB[129]. - The company recorded interest income of CNY 3,434,421.17, a decrease from CNY 5,424,770.60 in the previous year, indicating a decline of 36.7%[121]. Market and Industry Trends - The packaging and printing industry is experiencing a shift towards high-quality development, with a focus on domestic market growth due to the stable performance of the tobacco industry[24]. - In the first half of 2021, the national cigarette production increased by 2.1 billion sticks, a year-on-year growth of 1.65%, which positively impacted the cigarette label market[25]. - The market for sauce-flavored liquor has seen a significant increase, with industry sales revenue reaching approximately ¥155 billion, a year-on-year growth of about 14%[28]. - The company is expanding its focus on liquor box packaging, which is highly correlated with the recovery of the liquor industry post-pandemic[27]. Research and Development - The company’s R&D expenses increased by 5.45% to approximately ¥10.02 million from ¥9.50 million year-on-year[47]. - The company designed and developed a total of 52 new products during the reporting period, including 8 design schemes for Guizhou Zhongyan[43]. - The company aims to optimize its industrial layout and cultivate new profit growth points through ongoing research and development in the cannabis application field[30]. Environmental Compliance - The company has implemented strict wastewater treatment measures, ensuring that all production wastewater is recycled and treated, with no external discharge[76]. - The company has received the "Pollutant Discharge Permit" issued by the Guizhou Provincial Environmental Protection Bureau, indicating compliance with environmental regulations[79]. - The company has established effective noise reduction measures in its production facilities, ensuring compliance with noise pollution standards[77]. - The company has successfully maintained the operation of its pollution control facilities, with monitoring results meeting national standards[78]. Shareholder Information - The total number of ordinary shareholders as of the end of the reporting period is 17,025[97]. - The largest shareholder, Guizhou Yongji Real Estate Development Co., Ltd., holds 172,566,200 shares, accounting for 41.18% of the total shares[99]. - The company has not proposed any stock bonus or capital reserve increase in its profit distribution plan, focusing solely on cash dividends[71]. Risk Management - The report includes a risk statement indicating that future plans and strategies do not constitute a commitment to investors, highlighting the importance of investment risk awareness[5]. - The company is facing risks related to product pricing declines and the impact of the ongoing global pandemic on operations[60]. - The company has identified risks related to overseas investments, particularly in the medical cannabis sector, and is monitoring macroeconomic and policy changes that could impact operations[63]. Corporate Governance - The company has elected new independent directors, indicating a change in its board composition[70]. - The company has committed to a three-year shareholder return plan for 2020-2022, reflecting its focus on shareholder value[71].